Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Towards the clinical implementation of pharmacogenetics in bipolar disorder.

BMC medicine - 30 May 2014

Salloum Naji C, McCarthy Michael J, Leckband Susan G, Kelsoe John R

Abstract excerpt

BACKGROUND: Bipolar disorder (BD) is a psychiatric illness defined by pathological alterations between the mood states of mania and depression, causing disability, imposing healthcare costs and elevating the risk of suicide. Although effective treatments for BD exist, variability in outcomes leads to a large number of treatment failures, typically followed by a trial and error process of medication switches that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Anticonvulsants
Share to Antidepressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antipsychotic Agents

Share to Bipolar Disorder

Share to Precision Medicine

Share to Research Design

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 24885933
DOI: 10.1186/1741-7015-12-90
PMCID: PMC4039055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Towards the clinical implementation of pharmacogenetics in bipolar disorder.PMID 24885933Read ↗

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selectionSemantic proximity Read ↗

Pharmacogenomic aspects of bipolar disorder: An updateSemantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates– A Mayo Clinic Bipolar Disorder Biobank StudySemantic proximity Read ↗

Genomics of Bipolar Disorder: What the Clinician Needs to Know.Semantic proximity Read ↗

Genetics of bipolar disorder: Translating discoveries to biological insights and clinical decision support.Semantic proximity Read ↗

Pharmacogenetics of lithium response in bipolar disorder.Semantic proximity Read ↗

Exploring the genetics of lithium response in bipolar disordersSemantic proximity Read ↗

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression.Semantic proximity Read ↗

Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?Semantic proximity Read ↗

Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.Semantic proximity Read ↗

[Genetics of bipolar disorder].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.